aod9604 fat loss muscle preservation safety AOD 9604 Peptide for Weight Loss: Weight and Vitality: Medical Weight Loss AOD-9604 Peptide: Fat Loss &

Mechanistic themes seen in preclinical research In animal and mechanistic work, AOD-9604 has been associated with: Increased lipolysis (breaking down stored fat) Reduced lipogenesis (reducing fat storage) Interactions with -adrenergic pathways in adipose tissue have been discussed as part of its lipolytic signaling profile (OUP Academic) In obese animal models, AOD-9604 has shown reductions in body weight and body fat and changes consistent with increased fat mobilization

Talk to a patient care advisor free, confidential, 24/7

Safety data is limited to the preclinical studies, where no adverse events were reported at therapeutic doses during the 11-week treatment period the longest published study duration

Two approaches are common in research practice: filling empty capsules, or dissolving a measured amount in liquid

After this period, injections can be administered once per month, which this frequency is enough to reverse the signs of vitamin B12 deficiency

1,2,6 Skin hyperpigmentation, glossitis, and infertility have also been reported